Replimune Group, Inc. (REPL) is a Healthcare stock tracked by StreetAlpha. It last closed at $14.63 on Aug 17, down 4.00% on the day. REPL reports earnings on Thu, Nov 5, 2026. The average 12-month price target from 4 analysts is $16.75 (+14.5% from the last close), with a high of $21.00 and a low of $12.00. Analyst consensus is Strong Buy, based on the latest ratings from 4 firms (3 buy, 1 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in REPL, 0% of them bullish and 100% bearish.
Each firm's latest rating on REPL in the past 90 days
Average 12-month target
$16.75
▲ 14.5% upside
Based on 4 analysts who set a price target on REPL in the past 90 days. The average target is $16.75, with a high of $21.00 and a low of $12.00, compared with the last close of $14.63.
Highest target$21.00
Average target$16.75
Lowest target$12.00
Latest rating changes
Roth MKMInitiated
Sep 25Buy$17
JP MorganTarget raised
Aug 26Buy$20 → $21
JP MorganMaintained
Aug 7Buy$20
Leerink PartnersUpgrade
Aug 4Buy$2 → $17
WedbushTarget raised
Jul 31Hold$9 → $12
Date
Firm
Action
Rating
Price target
Sep 25
Roth MKM
Initiated
Buy
$17
Aug 26
JP Morgan
Target raised
Buy
$20 → $21
Aug 7
JP Morgan
Maintained
Buy
$20
Aug 4
Leerink Partners
Upgrade
Buy
$2 → $17
Jul 31
Wedbush
Target raised
Hold
$9 → $12
Loading…
Whale Options Flow
90D
Total alerts
1
Bullish
0
0%
Bearish
1
100%
Date span
Jul 13 – Jul 13
Loading…
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether REPL is in one of them and how their past REPL trades turned out.
